Belviq (lorcaserin) Attorney

Lawyer for Belviq Cancer

A medicine meant to help you lose weight shouldn’t make you sicker. However, fears that the weight-loss medications Belviq® and Belviq XR®, as well as the extended-release version, Belviq XR®, may raise the risk of cancer caused maker Eisai to pull them off the market in the United States in February 2020. Those who took Belviq or Belviq XR and were diagnosed with cancer may be entitled to money and should seek legal counsel. Call us at 713-654-4040 or 1-800-883-9858. 

Background on Belviq Withdrawal

Weight-loss medications that require a prescription like  Belviq and Belviq XR are advertised as a solution to aid people with obesity feel satisfied when on low-calorie diets. Belviq was also recommended to overweight and obese people to address hypertension and diabetes. The FDA authorized the medicine in 2012, but it was contingent on Eisai undertaking a clinical trial to determine the drug’s safety and quality. The drug was manufactured by Arena Pharmaceuticals Gmbh in Switzerland. 

Japanese drugmaker Eisai conducted a five-year analysis that looked at a double-blind study on 12,000 patients and discovered that individuals who took Belviq were diagnosed with cancer at a greater incidence than those who took a placebo. 

The FDA declared in January 2020, after analyzing the trial data, that the medicine was probably linked to an elevated risk of various forms of cancer, including colorectal, lung, and pancreatic.

The FDA requested that Eisai remove the medicine from the U.S. market within weeks of its announcement, and Eisai responded by asking the FDA to voluntarily withdraw the drug.

As a response, the FDA advised physicians to discontinue prescribing Belviq and generic lorcaserin, inform patients using Belviq or lorcaserin about the elevated cancer risk identified in the clinical study, and explore alternate pharmaceutical or weight-loss options with them.

Patients and health providers who notice negative side effects or a malignancy such as pancreatic, colorectal, or lung cancer in a patient who took Belviq should contact the FDA.

If I’ve Been Diagnosed with Cancer can a Lorcaserin Attorney Help me With a Legal Claim Against Belviq? 

You may be eligible for compensation if you or a loved one acquired pancreatic, lung, or colorectal cancer after using Belviq, Belviq XR, or Lorcaserin. You may be entitled to monetary compensation for your losses, which include:

  • Medical costs from the past, present, and future
  • Suffering and pain
  • Wages and earning potential have been lost.
  • Companionship loss (Loss of Consortium) 
  • Punitive damages, if necessary

You may be entitled to submit a wrongful death claim if a loved one died because of cancer caused by Belviq or Belviq XR. Of course, no amount of money will bring them back or compensate for the emptiness left by their departure, but you can make a claim to cover funeral and burial costs, as well as pain and suffering and any previous expenditures paid as a result of their sickness.

Contact a Belviq Lawyer to File a Claim for Cancer Diagnosis or Death

We have been helping victims of dangerous drugs for nearly 40 years at the Willis Law Firm. We understand what it takes to manage situations as extensive and complicated as the Belviq litigation. David P. Willis is board certified as a personal injury trial law specialist. Our Belviq attorneys in Houston assist patients and families around the United States, and we do it with remarkable experience and success. Please call us at 713-654-4040 or 1-800-883-9858 if you or someone you care about has been injured by taking Belviq.

Don't Pay
Until We
We Can Help
Practice Areas
Free Case Review